Clinical Pharmacology & Therapeutics · 1983 · 103 citations · 12 references
MedicineBiochemistryPharmacologyDrug MetabolismMetabolismPharmacogeneticsDrug Metabolism GeneticsDrug-metabolizing EnzymesMetabolic VariabilityMetabolism VariabilityMetabolite IdentificationPopulation PharmacogeneticsCaffeine MetabolismCaffeine PharmacologyClinical Pharmacology EvidenceDrug Metabolism PolymorphismsDrug Metabolism VariationDrug-metabolizing Enzyme VariabilityMetabolism Enzyme PolymorphismsN-acetyltransferase-mediated Metabolism
In the course of investigations into variability in the metabolism of caffeine in human populations, urinary levels of 5-acetylamino-6-formylamino-3-methyluracil (AFMU), a newly discovered ring-opened metabolite of caffeine, were found to be both bimodally distributed and interethnically variable in samples (Caucasian: n = 42; Oriental: n = 26) from the Toronto population. To test the premise that the polymorphic N-acetyltransferase enzyme (E.C.2.3.1.5) could be responsible for the production of AFMU, 20 of the subjects were phenotyped for acetylator status using sulfamethazine (SMZ). Concordance for all subjects between AFMU production and SMZ acetylation strongly suggests that the acetylation polymorphism is involved in the formation of AFMU in man.
12
Caffeine disposition after oral doses
Maurizio Bonati, Roberto Latini, Ferruccio Galletti et al. · Clinical Pharmacology & Therapeutics · 1982 · 355 citations
Methylxanthines in Apnea of Prematurity
Jacob V. Aranda, Tomris Türmen · Clinics in Perinatology · 1979 · 209 citations
Medicine, Pediatrics, Pharmacology +10